<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">46576164X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111901.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19900301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF03000489</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF03000489</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Immunocytochemical evaluation abl-Gene products in Leukemic Cell Lines</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Sohei Kitazawa, Sakan Maeda, Taketoshi Sugiyama]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">We raised monoclonal antibody (MAb) against a synthetic oligopeptide corresponding to a portion of the predictedv-abl protein sequence (379-390). This MAb reacted with all of theabl-gene products (pl45c-abl, pl50c-abl and 210bcr-abl fused protein) and was not specific for any one of them. Immunocytochemically, we investigated the expression and localization of theabl-gene products in various leukemic cell lines. Positive immunoreactions were observed in Ph1 positive leukemic cell lines (K562 and KU-812) and erythro-leukemic cell lines (HEL and K3D) and were located on the cell membrane. Electron microscopically, a different distribution pattern was observed among the cell lines: linear and almost even in Ph1 positive leukemic cell lines, whereas spotted or budding-like in erythroleukemic cell lines. Ph1 translocation produces p210nbcr-abl fused protein with not only altered autophosphorylation activities but also altered subcellular distribution patterns.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Humana Press Inc., 1990</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Leukemia</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Oncogene</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">c- abl</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Monoclonal antibody</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Immunocytochemistry</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kitazawa</subfield>
   <subfield code="D">Sohei</subfield>
   <subfield code="u">2nd Department of Pathology, Kobe University, School of Medicine, 7-5-1 Kusuniki-cho, Kobe 650, Chuo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Maeda</subfield>
   <subfield code="D">Sakan</subfield>
   <subfield code="u">2nd Department of Pathology, Kobe University, School of Medicine, 7-5-1 Kusuniki-cho, Kobe 650, Chuo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sugiyama</subfield>
   <subfield code="D">Taketoshi</subfield>
   <subfield code="u">2nd Department of Pathology, Kyoto University, School of Medicine, Yoshida Konoe-cho, Kyoto 606, Sakyo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Medical Oncology and Tumor Pharmacotherapy</subfield>
   <subfield code="d">Humana Press</subfield>
   <subfield code="g">7/1(1990-03-01), 35-41</subfield>
   <subfield code="x">0736-0118</subfield>
   <subfield code="q">7:1&lt;35</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">7</subfield>
   <subfield code="o">12032</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF03000489</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF03000489</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kitazawa</subfield>
   <subfield code="D">Sohei</subfield>
   <subfield code="u">2nd Department of Pathology, Kobe University, School of Medicine, 7-5-1 Kusuniki-cho, Kobe 650, Chuo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Maeda</subfield>
   <subfield code="D">Sakan</subfield>
   <subfield code="u">2nd Department of Pathology, Kobe University, School of Medicine, 7-5-1 Kusuniki-cho, Kobe 650, Chuo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sugiyama</subfield>
   <subfield code="D">Taketoshi</subfield>
   <subfield code="u">2nd Department of Pathology, Kyoto University, School of Medicine, Yoshida Konoe-cho, Kyoto 606, Sakyo-ku, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Medical Oncology and Tumor Pharmacotherapy</subfield>
   <subfield code="d">Humana Press</subfield>
   <subfield code="g">7/1(1990-03-01), 35-41</subfield>
   <subfield code="x">0736-0118</subfield>
   <subfield code="q">7:1&lt;35</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">7</subfield>
   <subfield code="o">12032</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
